Cost-effectiveness watchdog NICE has recommended routine NHS use of two new therapies for women with advanced breast cancer – Gilead's Trodelvy and Novartis' Piqray – in England.

Patients in England with a form of breast cancer will be offered a new treatment after it was given the green light for NHS use. The Institute of Cancer Research, London, (ICR) – which worked on ...

and now certain breast cancer patients can benefit from the drug on the NHS. “It’s fantastic news that olaparib has been approved for use on the NHS in England, providing a second targeted ...

there were 50,751 men diagnosed with prostate cancer in England, surpassing the 48,531 breast cancer diagnoses, according to NHS data. This trend became even more pronounced just a year later when ...

Prostate cancer has become England's most common cancer as more men are getting checked. Prostate Cancer UK analysis shows diagnoses of the disease overtook breast cancer in 2022 and 2023.

Thousands more over 50s will be sent a home-testing kit that can help to detect signs of bowel cancer, as the NHS expands its screening programme in England ... screening helpline on 0800 707 ...